Care or Innovation? Studying the Implementation of the Hospital Exemption in Denmark

Read full text Summarise with VIRAT
Authors: Zainab Afshan Sheikh, Lea Skovgaard, S. Wadmann, Jakob Blak Wested
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Advanced therapy medicinal products (ATMPs) are highly innovative, often personalized therapies regulated at European Union level. The hospital exemption is a regulatory mechanism that allows national authorities to permit clinical use of non-authorized ATMPs under specific conditions. Recent scientific and political debates about the use of hospital exemption for ATMPs predominantly focus on the need for uniform implementation across the EU, prompted by noticeable variation in national practices. Drawing on a case study from Denmark and insights from stakeholders working with ATMPs in several EU countries, this article analyses the Danish implementation of the hospital exemption and situates it in a broader European context. We argue that efforts toward harmonisation risk depoliticizing important questions about why the implementation of the hospital exemption differs across Member States. We suggest that the variation does not merely reflect technical differences in legal interpretation but appears closely related to different ways of balancing concern for patient access to treatment, patient safety, and medical innovation. Therefore, if harmonisation attempts are to succeed, they must consider the values they seek to align. Otherwise, such efforts may generate new political tensions rather than resolve existing ones. A reflexive understanding of the sources of variable implementation is essential for designing harmonisation strategies that are both legitimate and societally sustainable.

Fields of Study & Subjects

Biomedical Ethics and Regulation Healthcare Regulation Pharmaceutical Economics and Policy

Publication details

Journal / source
European Health & Pharmaceutical Law Review
Volume
9
Issue
1
Pages
32–43
Publication date
1 January 2026
Language
EN